" class="no-js "lang="en-US"> Medtronic Archives - Page 2 of 2 - Medtech Alert
Friday, July 25, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease | MTA

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Read more

Industry News

 Medtronic to Acquire Intersect ENT | Pharmtech Focus

Medtronic to Acquire Intersect ENT

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has entered […]

Equipment

 First Gynecological Procedures Performed with Medtronic Hugo ™ Robotic-Assisted Surgery System | Pharmtech Focus

First Gynecological Procedures Performed with Medtronic Hugo ™ Robotic-Assisted Surgery System

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first gynecological (GYN) […]

Artificial Intelligence

 Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring | Pharmtech Focus

Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug […]

Cardiovascular

 Medtronic TYRX ™ Absorbable Antibacterial Envelope Is Effective at Reducing Infections in Cardiac Device Patients with Hematomas | Pharmtech Focus

Medtronic TYRX ™ Absorbable Antibacterial Envelope Is Effective at Reducing Infections in Cardiac Device Patients with Hematomas

Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced new data from […]

Cardiovascular

 Robocath Completes First Robotic Angioplasties in Belgium | Pharmtech Focus

Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease

Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the launch of the Prevail™ […]

Equipment

 First Procedure in the World with Medtronic Hugo™ Robotic-Assisted Surgery System Performed at Clínica Santa Maria in Chile | Pharmtech Focus

First Procedure in the World with Medtronic Hugo™ Robotic-Assisted Surgery System Performed at Clínica Santa Maria in Chile

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first patient procedure […]

Central Nervous System

 Medtronic Announces FDA Approval of its Next Generation Recharge-Free Spinal Cord Stimulation Platform | Pharmtech Focus

Medtronic Announces FDA Approval of its Next Generation Recharge-Free Spinal Cord Stimulation Platform

Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced it has received […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients

    Clinical Trials

     Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS

    Clinical Trials

     Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board

    Appointments

     Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

    News

     Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

    Clinical Trials

     Read more